Repare Therapeutics Announces Positive Initial Data at Esmo Gi From Phase 1 Minotaur Trial Evaluating Lunresertib in Combination With Folfiri
Repare Therapeutics宣佈Esmo Gi第1期Minotaur試驗評估Lunresertib與Folfiri聯合應用的初步正面數據。
Repare Therapeutics Announces Positive Initial Data at Esmo Gi From Phase 1 Minotaur Trial Evaluating Lunresertib in Combination With Folfiri
Repare Therapeutics宣佈Esmo Gi第1期Minotaur試驗評估Lunresertib與Folfiri聯合應用的初步正面數據。
譯文內容由第三人軟體翻譯。